Skip To Content

Study ID: Vyriad Solid Tumor VYR-VSV2-101

Title:

Phase I Trial of Intratumoral Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and human interferon beta (VSV-IFN-ß-NIS), in Patients with Refractory Solid Tumors

Location:
Sioux Falls Region
Principal Investigator:
Steven Powell, MD
Disease:
Other
Stage:
Phase I
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.